INS and gestational diabetes: Further studies with longer follow-up periods, to assess maternal and neonatal outcomes in the medium and long term, are needed to add higher quality evidence and to better evaluate the use of metformin in GDM, since there was no standardization of medication doses and each study used different regimens of metformin and insulin therapy without direct comparison between the two medications.